• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Raysearch Laboratories

196.00 SEK+4.14 %14.8, 16.12
Less than 1K followers

RAY B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+4.14 %
-15.44 %
+8.53 %
+5.72 %
-14.04 %
-29.62 %
+184.06 %
+142.57 %
+251.41 %

RaySearch Laboratories operates in the medical technology industry and focuses on the development and manufacture of software for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The operations are international and target customers globally. RaySearch Laboratories was founded in 2000 and is headquartered in Stockholm, Sweden.

Read more
Market cap
6.72B SEK
Turnover
154.61M SEK
Revenue
1.34B
EBIT %
21.74 %
P/E
29.47
Dividend yield-%
2.04 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
3.11
2026

Interim report Q3'26

10.2
2027

Annual report '26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release13.08.2026, 13.50

Redeye: RaySearch Laboratories (Q2 Initial take): Confidence in a strong H2

Raysearch Laboratories
Regulatory press release13.08.2026, 07.30

Interim report second quarter 2026: Delayed USA orders weighed on second quarter

Raysearch Laboratories
Press release12.08.2026, 16.20

Redeye: Top Picks: A Summary of July

Raysearch Laboratories

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release10.08.2026, 11.20

Strong order momentum in the USA at the start of the third quarter

Raysearch Laboratories
Press release07.08.2026, 08.25

RaySearch receives RayStation order from University of North Carolina School of Medicine

Raysearch Laboratories
Press release03.08.2026, 10.10

Invitation to presentation of RaySearch’s interim report for the second quarter of 2026

Raysearch Laboratories
Press release17.07.2026, 09.51

RaySearch to present automation, speed, and analytics advancements at AAPM 2026

Raysearch Laboratories
Regulatory press release16.07.2026, 15.05

Preliminary results for the second quarter of 2026

Raysearch Laboratories
Press release07.07.2026, 09.19

RaySearch releases RayCare v2026

Raysearch Laboratories
Press release03.07.2026, 09.23

Yonsei Cancer Center expands use of RayStation

Raysearch Laboratories
Press release01.07.2026, 14.34

RaySearch releases RayStation v2026

Raysearch Laboratories
Press release29.06.2026, 12.56

RayIntelligence v2026: Advancing oncology analytics

Raysearch Laboratories
Regulatory press release26.06.2026, 10.45

Utilization of authorization to acquire own shares

Raysearch Laboratories
Press release18.06.2026, 10.15

RaySearch enters the Vietnamese market

Raysearch Laboratories
Regulatory press release16.06.2026, 14.14

Utilization of authorization to acquire own shares

Raysearch Laboratories
Press release05.06.2026, 09.35

RaySearch to showcase new advances in particle therapy at PTCOG 64

Raysearch Laboratories
Press release21.05.2026, 13.38

Antony Lomax joins RaySearch to strengthen leadership in particle therapy

Raysearch Laboratories
Press release18.05.2026, 09.06

First patients treated with RayCare at Raigmore Hospital

Raysearch Laboratories
Press release13.05.2026, 17.30

RaySearch to showcase groundbreaking innovations at ESTRO 2026

Raysearch Laboratories
Press release12.05.2026, 10.05

First online adaptive treatment on TrueBeam using RayStation and RayCare

Raysearch Laboratories